title: Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.
abstract: OBJECTIVE
  We tested the hypothesis that thinner-strut stents are associated with a reduced rate of restenosis when comparing two stents with different design.
  
  
  BACKGROUND
  We have previously shown that, for two stents with similar design, the risk for restenosis is dependent on the strut thickness. It is unknown whether strut thickness preserves its relevance as a determinant of restenosis even in the presence of different stent designs.
  
  
  METHODS
  A total of 611 patients with symptomatic coronary artery disease were randomly assigned to receive either the thin-strut ACS RX Multilink stent (Guidant, Advanced Cardiovascular Systems, Santa Clara, California) (strut thickness 50 microm, interconnected ring design; n = 309) or the thick-strut BX Velocity stent (Cordis Corp., Miami, Florida) (strut thickness 140 microm, closed cell design; n = 302). The primary end point was angiographic restenosis (> or =50% diameter stenosis at follow-up angiography). Secondary end points were the incidence of target-vessel revascularization (TVR) and the combined rate of death and myocardial infarction (MI) at one year.
  
  
  RESULTS
  The incidence of angiographic restenosis was 17.9% in the thin-strut group and 31.4% in the thick-strut group, relative risk, 0.57 (95% confidence interval, 0.39 to 0.84), p < 0.001. A TVR due to restenosis was required in 12.3% of the thin-strut group and 21.9% of the thick-strut group, relative risk, 0.56 (95% confidence interval, 0.38 to 0.84), p = 0.002. No significant difference was observed in the combined incidence of death and MI at one year.
  
  
  CONCLUSIONS
  When two stents with different design are compared, the stent with thinner struts elicits less angiographic and clinical restenosis than the thicker-strut stent.
authors.affiliation: Deutsches Herzzentrum, Munich, Germany.
authors.forename: Jürgen
authors.initials: J
authors.lastname: Pache
authors.forename: Adnan
authors.initials: A
authors.lastname: Kastrati
authors.forename: Julinda
authors.initials: J
authors.lastname: Mehilli
authors.forename: Helmut
authors.initials: H
authors.lastname: Schühlen
authors.forename: Franz
authors.initials: F
authors.lastname: Dotzer
authors.forename: Jörg
authors.initials: J
authors.lastname: Hausleiter
authors.forename: Martin
authors.initials: M
authors.lastname: Fleckenstein
authors.forename: Franz Josef
authors.initials: FJ
authors.lastname: Neumann
authors.forename: Ulrich
authors.initials: U
authors.lastname: Sattelberger
authors.forename: Claus
authors.initials: C
authors.lastname: Schmitt
authors.forename: Martina
authors.initials: M
authors.lastname: Müller
authors.forename: Josef
authors.initials: J
authors.lastname: Dirschinger
authors.forename: Albert
authors.initials: A
authors.lastname: Schömig
mesh_terms: D000368:Aged; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000517:prevention & control*; D023921:Coronary Stenosis / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D004867:Equipment Design; D005260:Female; D006439:Hemodynamics; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015607:Stents; D016896:Treatment Outcome